Acetazolamide recalls
Acetazolamide products have been recalled 2 times, most recently on 25 Sep 2024. The recalling company is usually Rubicon Research Private. The most common reason is manufacturing (cgmp) deviations.
Total recalls2since 2021
Last 12 months0reported
Class I00% of total
Ongoing1latest 25 Sep 2024
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 1 50%Class III 1 50%
Why acetazolamide is recalled
Companies
By year
Ongoing acetazolamide recalls
1 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS III | AcetaZOLAMIDE Tablets, USP, 125 mg bottled recalledAcetazolamide | Rubicon Research Private | Other | Nationwide |
All acetazolamide recalls, newest first
2 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS III | AcetaZOLAMIDE Tablets, USP, 125 mg bottled recalledAcetazolamide | Rubicon Research Private | Other | Nationwide |
| Drug | CLASS II | AcetaZOLAMIDE Tablets, USP 125 mg recalled by Cardinal HealthAcetazolamide | Cardinal Health | Manufacturing (CGMP) Deviations | FL, GA, SC |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.